CONCENTRATION	3 Months Ended
Oct. 31, 2023
CONCENTRATION
CONCENTRATION	NOTE 6 – CONCENTRATION Revenue On March 1, 2022, the Company entered in a consulting agreement in the field of Healthcare with a monthly fee of $8,333, with First DP Ventures, LP. The services were performed by a member of the Company’s board of directors pursuant to an Employment Contract. During the three months ended October 31,2023 and 2022, all revenue of $25,000 and $25,001 and accounts receivable of $8,333 and $8,333 were derived from one customer, respectively. Cost of revenue During the three months ended October 31,2023, and 2022, the cost of revenue of $22,900 and $22,894 was for the payroll expenses related to a member of the Company’s board of directors, who performed the consulting services.

The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 275
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//275/tableOfContent

Name:	us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration